TABLE OF CONTENTS
Volume 68, Issue S99 (December 2005)
I. CKD |
II. Epidemiology |
III. Progression of CKD |
IV. Diabetic Nephropathy |
V. Chronic Allograft Nephropathy |
VI. Interventions in CKD
Introduction
Introduction
ÁNGEL L M DE FRANCISCO
Kidney Int 68: S1-S1; doi:10.1111/j.1523-1755.2005.09900.x
I. CKD
The renal benefits of a healthy lifestyle
ANGÉL L M DE FRANCISCO, GEMA GERNÁNDEZ FRESNEDO, ROSA PALOMAR, CELESTINO PIÑERA and MANUEL ARIAS
Kidney Int 68: S2-S6; doi:10.1111/j.1523-1755.2005.09901.x
The need for optimal and coordinated management of CKD
ADEERA LEVIN
Kidney Int 68: S7-S10; doi:10.1111/j.1523-1755.2005.09902.x
Replicative senescence in patients with chronic kidney failure
ROSARIO JIMENEZ, JULIA CARRACEDO, RAFAEL SANTAMARÍA, SAGRARIO SORIANO, JOSE J MADUEÑO, RAFAEL RAMÍREZ, MARIANO RODRÍGUEZ, ALEJANDRO MARTÍN-MALO and PEDRO ALJAMA
Kidney Int 68: S11-S15; doi:10.1111/j.1523-1755.2005.09903.x
II. Epidemiology
Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study
ALFONSO OTERO, PILAR GAYOSO, FERNANDO GARCIA and ÁNGEL L DE FRANCISCO ON BEHALF OF THE EPIRCE STUDY GROUP
Kidney Int 68: S16-S19; doi:10.1111/j.1523-1755.2005.09904.x
Epidemiology of diabetic nephropathy in Spain
ALBERTO MARTÍNEZ-CASTELAO, FERNANDO DE ALVARO and JOSÉ LUIS GÓRRIZ
Kidney Int 68: S20-S24; doi:10.1111/j.1523-1755.2005.09905.x
Chronic renal failure: A cardiovascular risk factor
JOAN FORT
Kidney Int 68: S25-S29; doi:10.1111/j.1523-1755.2005.09906.x
Chronic kidney disease: A European perspective
NORBERT LAMEIRE, KITTY JAGER, WIM VAN BIESEN, DIRK DE BACQUER and RAYMOND VANHOLDER
Kidney Int 68: S30-S38; doi:10.1111/j.1523-1755.2005.09907.x
III. Progression of CKD
The Rho-kinase pathway regulates angiotensin II-induced renal damage
MÓNICA RUPÉREZ, ELSA SÁNCHEZ-LÓPEZ, LUIS MIGUEL BLANCO-COLIO, VANESA ESTEBAN, JUAN RODRÍGUEZ-VITA, JUAN JOSÉ PLAZA, JESÚS EGIDO and MARTA RUIZ-ORTEGA
Kidney Int 68: S39-S45; doi:10.1111/j.1523-1755.2005.09908.x
Role of hypoxia in the pathogenesis of renal disease
KAI-UWE ECKARDT, WANJA W BERNHARDT, ALEXANDER WEIDEMANN, CHRISTINA WARNECKE, CHRISTIAN ROSENBERGER, MICHAEL M WIESENER and CARSTEN WILLAM
Kidney Int 68: S46-S51; doi:10.1111/j.1523-1755.2005.09909.x
Systemic and glomerular hypertension and progression of chronic renal disease: The dilemma of nephrosclerosis
RAFAEL MARÍN, MANUEL GOROSTIDI, FRANCISCO FERNÁNDEZ-VEGA and RAFAEL ÁLVAREZ-NAVASCUÉS
Kidney Int 68: S52-S56; doi:10.1111/j.1523-1755.2005.09910.x
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease
GIUSEPPE REMUZZI, NORBERTO PERICO, MANUEL MACIA and PIERO RUGGENENTI
Kidney Int 68: S57-S65; doi:10.1111/j.1523-1755.2005.09911.x
Role of calcium-phosphorous disorders in the progression of renal failure
EBERHARD RITZ, MARIE-LUISE GROSS and RALF DIKOW
Kidney Int 68: S66-S70; doi:10.1111/j.1523-1755.2005.09912.x
Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase–dependent superoxide production in patients with early chronic kidney disease
ANA FORTUÑO, OSCAR BELOQUI, GORKA SAN JOSÉ, MARÍA U MORENO, GUILLERMO ZALBA and JAVIER DÍEZ
Kidney Int 68: S71-S75; doi:10.1111/j.1523-1755.2005.09913.x
Anemia management and chronic renal failure progression
JEROME ROSSERT, MARC FROISSART and CHRISTIAN JACQUOT
Kidney Int 68: S76-S81; doi:10.1111/j.1523-1755.2005.09914.x
Tubulointerstitial damage and progression of renal failure
BERNARDO RODRÍGUEZ-ITURBE, RICHARD R JOHNSON and JAIME HERRERA-ACOSTA
Kidney Int 68: S82-S86; doi:10.1111/j.1523-1755.2005.09915.x
Dyslipidemia and the progression of renal disease in chronic renal failure patients
ALEIX CASES and ELISABET COLL
Kidney Int 68: S87-S93; doi:10.1111/j.1523-1755.2005.09916.x
IV. Diabetic Nephropathy
Genetics of progressive renal failure in diabetic kidney disease
YONGMEI LIU and BARRY I FREEDMAN
Kidney Int 68: S94-S97; doi:10.1111/j.1523-1755.2005.09917.x
Tumor necrosis factor-
gene expression in diabetic nephropathy: Relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition
JUAN J NAVARRO, FRANCISCO F MILENA, CARMEN MORA, CANDELARIA LEÓN, FELIX CLAVERIE, CARLOS FLORES and JAVIER GARCÍA
Kidney Int 68: S98-S102; doi:10.1111/j.1523-1755.2005.09918.x
Proteomic approach in the search of new cardiovascular biomarkers
JULIO GALLEGO-DELGADO, ALBERTO LAZARO, JULIO J OSENDE, MARIA M BARDERAS, LUIS L BLANCO-COLIO, MARIA CARMEN DURAN, JOSE J MARTIN-VENTURA, FERNANDO VIVANCO and JESUS EGIDO
Kidney Int 68: S103-S107; doi:10.1111/j.1523-1755.2005.09919.x
V. Chronic Allograft Nephropathy
Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations
JEREMY J CHAPMAN
Kidney Int 68: S108-S112; doi:10.1111/j.1523-1755.2005.09920.x
Risk factors associated with the deterioration of renal function after kidney transplantation
DANIEL SERÓN, XAVIER FULLADOSA and FRANCESC MORESO
Kidney Int 68: S113-S117; doi:10.1111/j.1523-1755.2005.09921.x
Non-immunologic intervention in chronic allograft nephropathy
MANUEL ARIAS, GEMA FERNÁNDEZ-FRESNEDO, EMILIO RODRIGO, JUAN JARLOS RUIZ, JULIO GONZÁLEZ-COTORRUELO and CARLOS GÓMEZ-ALAMILLO
Kidney Int 68: S118-S123; doi:10.1111/j.1523-1755.2005.09922.x
Immunosuppressive treatment and progression of histologic lesions in kidney allografts
JOSE J MORALES
Kidney Int 68: S124-S130; doi:10.1111/j.1523-1755.2005.09923.x
VI. Interventions in CKD
Ischemic nephropathy: Detection and therapeutic intervention
JOSÉ A GARCÍA-DONAIRE and JOSÉ M ALCÁZAR
Kidney Int 68: S131-S136; doi:10.1111/j.1523-1755.2005.09924.x
Therapeutic measures in proteinuric nephropathy
MANUEL PRAGA
Kidney Int 68: S137-S141; doi:10.1111/j.1523-1755.2005.09925.x
Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives
KEITH A HRUSKA, SURESH MATHEW, MATTHEW M DAVIES and RICHARD R LUND
Kidney Int 68: S142-S151; doi:10.1111/j.1523-1755.2005.09926.x
